The small study in patients with a rare disorder that causes liver and lung damage showed the potential for precisely ...

Idiopathic pulmonary fibrosis is a progressive and life-threatening lung disease but there are ASX companies bringing hope to ...

Patients with chronic spontaneous urticaria that was not controlled with H1 antihistamines experienced improvements in itch ...

According to Roche subsidiary Genentech, which announced the label expansion on Monday, TNKase is the first new drug for ...

Operator Welcome to BioNTech's fourth quarter and full year 2024 earnings call. I would like to hand the call over to Michael ...

Mississippi Baptist Medical Center teamed up with Genentech to bring awareness of healthy lungs for Lung Cancer Awareness Month. An exhibit of inflatable lungs was set up Wednesday in the hospital ...

--(BUSINESS WIRE)--Genentech, a member of the Roche Group ... respiratory tract infections including infections of the lungs, cold symptoms, and pain or swelling of the nose or throat viral ...

F. Hoffmann-La Roche, one of the world’s largest biotechnology companies, announced on Thursday that it will establish an ...

Small cell lung cancer is a tumor type with notable ... Autogene cevumeran aka BNT122 developed in partnership with Genentech is based on the iNeST platform. iNeST targets neoantigens, unique ...